|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.EG |
First Approval Date19 Feb 2013 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
Evaluation of the Efficacy, safety, and tolerability of Difluprednate 0.05% versus Prednisolone acetate 1% eye drops following uneventful phacoemulsification surgery
100 Clinical Results associated with Orchidia Pharmaceutical Industries
0 Patents (Medical) associated with Orchidia Pharmaceutical Industries
100 Deals associated with Orchidia Pharmaceutical Industries
100 Translational Medicine associated with Orchidia Pharmaceutical Industries